Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

On May 18, 2022, Sensus Healthcare (Nasdaq: SRTS) announced its participation in the H.C. Wainwright Global Investment Conference, scheduled for May 23-26, 2022. The company will present on May 25 at 9:30 a.m. Eastern time, with the presentation available live and archived on its website. Additionally, Sensus management, including President Michael Sardano and CFO Javier Rampolla, will hold one-on-one meetings with investors during the conference. Sensus specializes in non-invasive treatments for oncological and non-oncological conditions, utilizing proprietary low-energy X-ray technology.

BOCA RATON, Fla, May 18, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be participating in the H.C. Wainwright Global Investment Conference taking place virtually and in-person at the Fontainebleau Miami Beach May 23-26, 2022. 

Sensus management will deliver a corporate presentation on May 25 at 9:30 a.m. Eastern time, and the live and archived presentation will be available on the Company’s website here.  In addition, Michael Sardano, president and general counsel, and Javier Rampolla, chief financial officer, will be holding one-on-one meetings with the investment community both virtually and in-person at the conference.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. Sensus offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100^™, SRT-100+^™ and SRT-100 Vision^™ systems. With its portfolio of innovative medical device products, including aesthetic lasers and its needleless TransDermal Infusion System^™, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit www.sensushealthcare.com.

Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com

#   #   #

FAQ

What is the date and time of Sensus Healthcare's presentation at the H.C. Wainwright Global Investment Conference?

Sensus Healthcare's presentation is scheduled for May 25, 2022, at 9:30 a.m. Eastern time.

Where can I watch the archived presentation of Sensus Healthcare?

The archived presentation of Sensus Healthcare will be available on their website after the live event.

Who from Sensus Healthcare will participate in one-on-one meetings at the conference?

Michael Sardano, President, and Javier Rampolla, CFO, will hold one-on-one meetings with investors.

What type of treatments does Sensus Healthcare offer?

Sensus Healthcare specializes in non-invasive treatments for oncological and non-oncological conditions using low-energy X-ray technology.

What is the significance of the H.C. Wainwright Global Investment Conference for Sensus Healthcare?

The conference provides Sensus Healthcare a platform to present its operations and innovations to the investment community.